Canaccord Adams Adds ArthroCare (ARTC) to 'Best Ideas' List for 2010
Tweet Send to a Friend
Canaccord Adams raises price target on ArthroCare (Nasdaq: ARTC) from $28 to $36, as the company relisted on Nasdaq.
Canaccord ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
